Table 2 Patient characteristics... | American Society of Hematology

Table 2

Patient characteristics (randomized patients only)

	T-cell leukemia		NHL		Total
	No HDM	HDM	No HDM	HDM	Total
Age at diagnosis, y
Younger than 10	85	78	31	38	232
10 or older	66	70	35	33	204
Sex
Male	109	111	52	55	327
Female	42	37	14	16	109
Race
White	113	116	51	56	336
Black	32	23	11	10	76
Other	6	9	4	4	23
Unknown	0	0	0	1	1
CNS status
No data	1	1	4	0	6
CNS 1	102	109	60	69	340
CNS 2	34	24	0	0	58
CNS 3	9	12	2	2	25
Bloody tap, blasts	3	2	0	0	5
Bloody tap, cannot interpret	1	0	0	0	1
Cranial nerve involvement only	1	0	0	0	1
WBC, × 1000/μL
< 50	61	64	66	71	262
50+	90	84	0	0	174
Lymphadenopathy
Missing	0	0	3	2	5
No	27	38	26	21	112
Yes	124	110	37	48	319
Mediastinal mass
No	59	63	11	13	146
Yes	92	85	55	58	290
Bulky disease (lymphadenopathy and mediastinal mass)
Missing	0	0	3	2	5
No	73	86	34	33	226
Yes	78	62	29	36	205
Splenomegaly (spleen palpable below umbilicus)
Missing	0	0	2	3	5
No	106	100	57	64	121
Yes	45	48	8	6	14
Stage (T-NHL only)
Missing			0	1	1
III			44	46	90
IV			23	26	49

	T-cell leukemia		NHL		Total
	No HDM	HDM	No HDM	HDM	Total
Age at diagnosis, y
Younger than 10	85	78	31	38	232
10 or older	66	70	35	33	204
Sex
Male	109	111	52	55	327
Female	42	37	14	16	109
Race
White	113	116	51	56	336
Black	32	23	11	10	76
Other	6	9	4	4	23
Unknown	0	0	0	1	1
CNS status
No data	1	1	4	0	6
CNS 1	102	109	60	69	340
CNS 2	34	24	0	0	58
CNS 3	9	12	2	2	25
Bloody tap, blasts	3	2	0	0	5
Bloody tap, cannot interpret	1	0	0	0	1
Cranial nerve involvement only	1	0	0	0	1
WBC, × 1000/μL
< 50	61	64	66	71	262
50+	90	84	0	0	174
Lymphadenopathy
Missing	0	0	3	2	5
No	27	38	26	21	112
Yes	124	110	37	48	319
Mediastinal mass
No	59	63	11	13	146
Yes	92	85	55	58	290
Bulky disease (lymphadenopathy and mediastinal mass)
Missing	0	0	3	2	5
No	73	86	34	33	226
Yes	78	62	29	36	205
Splenomegaly (spleen palpable below umbilicus)
Missing	0	0	2	3	5
No	106	100	57	64	121
Yes	45	48	8	6	14
Stage (T-NHL only)
Missing			0	1	1
III			44	46	90
IV			23	26	49

NHL indicates non-Hodgkin lymphoma; and HDM, high-dose methotrexate.